期刊文献+

吡格列酮对NOD鼠糖尿病的预防作用及其机制探讨 被引量:5

Preventive effects of pioglitazone and its mechanisms in the non-obese diabetic mouse
下载PDF
导出
摘要 目的探讨吡格列酮(PIO)对NOD鼠糖尿病发病率和胰岛炎的影响及其作用机制。方法4周龄NOD雌鼠随机分为2组,分别摄食0.02%PIO混合饲料(PIO,n=26)和普通饲料(对照组,n=25),观察30周龄时的糖尿病累积发病率。各组另取12周龄未患病NOD鼠(n=15)胰腺H-E染色观察胰岛炎;ELISA法测血清、脾细胞培养上清干扰素γ(IFN-γ)和白细胞介素4(IL-4)水平;RT-PCR检测脾脏IL-4、IFN-γ mRNA的表达水平。结果30周龄时,PIO组发病率较对照组明显降低(P<0.05)。12周龄时,PIO组胰岛炎平均积分低于对照组(P<0.05);血清、脾上清IL-4水平,脾脏IL-4 mRNA表达水平显著性高于对照组(P<0.05);PIO血清、脾上清IL-4/IFN-γ比值水平高于对照组(P<0.05)。结论PIO通过上调IL-4水平,促使免疫平衡向Th2方向偏移,从而使NOD鼠胰岛炎减轻,而在一定程度上预防和延缓NOD鼠糖尿病的发生。 Objective To explore the effects and mechanisms of pioglitazone on insulitis and diabetes in NOD mice. Methods Female NOD mice at 4 weeks of age were randomly derided into two groups, including 0.02% pioglitazone-mixed diet (pioglitazone group, n = 26), and pioglitazone-free diet (control group, n= 25). Pioglitazone was given in diet from 4 to 30 weeks of age. The accumulative diabetes incidence was followed-up to 30 weeks of age in each group of NOD mice. Pancreata were removed from NOD mice at 12 weeks of age in each group (n= 15) to score insulitis severity by routine H-E staining. Their spleens were for cell culture and total RNA extraction. IL-4 and IFN-γ levels in sera and supernatants of splenocytes were measured by ELISA. Spleen IL-4 and IFN-γ mRNA levels were detected by RT-PCR. Results At 30 weeks of age, the incidence of diabetes was 80.0% (20/ 25) in the control group and 53.8% (14/26) in the pioglitazone group. There was a significant reduction of diabetes incidence in NOD mice treated with pioglitazone (P〈0.05). The insulitis score of pioglitazone group was lower than that of controls (P〈0.05). IL-4 levels in sera and supernatants of splenocytes and spleen IL-4 mRNA levels were higher in pioglitazone group than in control group (P〈 0.05). The ratios of IL-4/IFN-γ in sera and supernatants of splenocytes were higher in pioglitazone group than in control group (P〈0.05). Conehmions Pioglitazone upregulates IL-4, induces a Th2- like response, and subsequently to some extent, lessens insulitis and reduces diabetes incidence in female NOD mice.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2007年第4期235-238,共4页 Chinese Journal of Diabetes
基金 国家自然科学基金资助项目(30370681)
关键词 NOD鼠 吡格列酮 糖尿病 1型 胰岛炎 辅助性T细胞 NOD mice Pioglitazone Diabetes, type 1 Insulitis T helper cell
  • 相关文献

参考文献9

  • 1Leiter EH. The NOD mouse: a model for insulin-dependent diabetes mellitus. Cur Prot Immunol, 1997, s24: 15.9.1-15.9.23.
  • 2Augstein P, Dunger A, Heinke P, et al. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells. Bioehem Biophys Res Commun, 2003, 304: 378-384.
  • 3裴剑浩,周智广,罗建华,蒋铁建,李霞,何凌.吡格列酮对非肥胖性糖尿病小鼠糖尿病的预防作用及机理探讨[J].中华医学杂志,2004,84(5):411-415. 被引量:18
  • 4罗建华,周智广,蒋铁建,裴剑浩,李霞,何凌,孙曙光.人谷氨酸脱羧酶65 DNA疫苗预防非肥胖糖尿病小鼠糖尿病的机制探讨[J].中华医学杂志,2004,84(21):1791-1795. 被引量:8
  • 5Abdelrahman M, Sivarajah A, Thiemermann C. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res, 2005, 65:772-781.
  • 6Diep QN, E1 Mabrouk M, Cohn JS, et al. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-7. Circulation, 2002, 105.. 2296-2302.
  • 7Natarajan C, Bright JJ. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Thl differentiation. Gene Immun, 2002, 3: 58-70.
  • 8Saubermann LJ, Nakajima A, Wada K, et al. Peroxisome proliferator-aetivated receptor-gamma agonist ligands stimulate a Th2 eytokine response and prevent acute colitis. Inflamm Bowel Dis, 2002,8:330-339.
  • 9Wang P, Anderson PO, Chen S, et al. Inhibition of the transcription factor AP-1 and NF-kappaB in CD4 + T cell by Peroxisome proliferator-activated receptor-gamma ligands. Int Immunopharmacol, 2001, 1: 803-812.

二级参考文献18

  • 1Eshima K, Mora C, Wong FS, et al. A crucial role of CD4 T cells as a functional source of CD154 in the initiation of insulin-dependent diabetes mellitus in the non-obese diabetic mouse. Int Immunol, 2003,35:351-357.
  • 2Kaufman DL, Clare-Salzler M, Tian J, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature, 1993, 366: 69-72.
  • 3Yoon JW, Yoon CS, Lim HW, et al. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β cells. Science ,1999, 284: 1183-1187.
  • 4Yang W, Zhou ZG, Yang ZL, et al. Investigation of glutamic acid decarboxylase and complete Freud′s adjuvant preventing insulitis and diabetes in NOD mice. Natl Med J Chin,1998,78:148-149.杨文,周智广,杨竹林,等. 谷氨酸脱
  • 5Balasa B, Boehm BO, Fortnage A, et al. Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 constimulation circumvents that protection. Clin Immunol,2001,1999: 241-252.
  • 6Tisch R, Wang B, Weaver DJ, et al. Antigen-specific mediated suppression of β cell autoimmunity by plasmid DNA Vaccination. J Immunol, 2001,166: 2122-2132.
  • 7Pei JH, Zhou ZG, Luo JH,et al. Preventive effects of pioglitazone on diabetes and relevant mechanisms, experimental study on non-obese diabetic mouse. Natl Med J Chin, 2004,84:411-415 裴剑浩,周智广,罗建华,等.吡格列酮对非
  • 8Lernmark A, Abdulahi P, Agardh CD, et al. A phase Ⅱ clinical trial involving alum-formulated GAD65 vaccination of GAD65-autoantibody positive adult diabetes patients. 63rd ADA. New Orleans, 2003.
  • 9Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol, 1997,15:297-322.
  • 10Tian J, Olcott AP, Hanssen LR, et al. Infectious Th1 and Th2 autoimmunity in diabetes-prone mice. Immunol Rev, 1998, 164:119-127.

共引文献20

同被引文献64

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部